Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-053049

Chief Financial Officer bought 10,000 shares at $4.40 ($43,979)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2021-08-19 Purchase +10,000 $4.40 $43,979 62,000 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $4.40 · $43,979
Loading xslF345X03/doc4.xml…